Effectiveness of intensification therapy in patients with type 2 diabetes who used basal insulin only

被引：0
|
作者：
Norrelund, H. [1 ]
Baggesen, L. M. [1 ]
Sogaard, M. [1 ]
Pedersen, L. [1 ]
Buhl, E. S. [2 ]
Haase, C. L. [2 ]
Johnsen, S. P. [1 ]
Thomsen, R. W. [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark
[2] Novo Nordisk Scandinavia AB, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
153
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [11] INTENSIFICATION OF BASAL INSULIN TREATMENT AMONG PATIENTS WITH DIABETES MELLITUS TYPE 2 IN THE NETHERLANDS
    Overbeek, J.
    Houben, E.
    Kring, S.
    Sommer, J.
    Penning-van Beest, F.
    van der Heijden, A.
    Nijpels, G.
    Herings, R.
    VALUE IN HEALTH, 2015, 18 (07) : A617 - A617
  • [12] Intensification of Basal Insulin Treatment Among Patients with Type 2 Diabetes Mellitus in the Netherlands
    Overbeek, Jetty A.
    Houben, Eline
    Kring, Sofia I.
    Briers, Jonathan
    Beest, Fernie J. A. Penning-van
    Van der Heijden, Amber A. W. A.
    Nijpels, Giel
    Herings, Ron M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 77 - 77
  • [13] Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes
    Mocarski, Michelle
    Yeaw, Jason
    Divino, Victoria
    DeKoven, Mitch
    Guerrero, German
    Langer, Jakob
    Thorsted, Brian Larsen
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (04): : 390 - 400
  • [14] Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting
    Davies, Melanie J.
    Glah, Divina
    Chubb, Barrie
    Konidaris, Gerasimos
    McEwan, Phil
    PHARMACOECONOMICS, 2016, 34 (09) : 953 - 966
  • [15] Basal insulin therapy in type 2 diabetes
    Bethel, MA
    Feinglos, MN
    JOURNAL OF THE AMERICAN BOARD OF FAMILY PRACTICE, 2005, 18 (03): : 199 - 204
  • [16] Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting
    Melanie J. Davies
    Divina Glah
    Barrie Chubb
    Gerasimos Konidaris
    Phil McEwan
    PharmacoEconomics, 2016, 34 : 953 - 966
  • [17] Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study
    Bellido, Diego
    Abellan, Pablo
    Palomar, Jose Manuel Ruiz
    Sintes, Rogelio Alvarez
    Nubiolae, Andreu
    Bellido, Virginia
    Romero, Gracia
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2018, 89 : 37 - 42
  • [18] Personalized intensification of insulin therapy in type 2 diabetes - does a basal-bolus regimen suit all patients?
    Giugliano, D.
    Sieradzki, J.
    Stefanski, A.
    Gentilella, R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (08) : 1425 - 1434
  • [19] Which basal insulin should be used in patients with type 2 diabetes mellitus?
    Clore J.N.
    Thurby-Hay L.
    Current Diabetes Reports, 2007, 7 (5) : 348 - 352
  • [20] Gradual intensification of premixed insulin lispro therapy vs basal ± mealtime insulin in patients with type 2 diabetes eating light breakfasts
    Giugliano, D.
    Woo, V.
    Shah, S.
    Tracz, M.
    Mistodie, C.
    Calle-Pascual, A.
    Duarte, R.
    Sari, R.
    Deinhard, J.
    Jiletcovici, A. O.
    Wille, S.
    Kiljanski, J.
    DIABETOLOGIA, 2012, 55 : S386 - S386
12345